US Stock MarketDetailed Quotes
OCX OncoCyte
- 2.4900
- -0.0350-1.39%
Close Apr 30 16:00 ET
33.28MMarket Cap-664P/E (TTM)
2.5900High2.4200Low18.09KVolume2.4900Open2.5250Pre Close45.77KTurnover0.32%Turnover RatioLossP/E (Static)13.36MShares5.882052wk High1.63P/B14.25MFloat Cap2.080052wk Low--Dividend TTM5.72MShs Float204.8000Historical High--Div YieldTTM6.73%Amplitude2.0800Historical Low2.5300Avg Price1Lot Size
About OncoCyte Company
OncoCyte Corp. is a molecular diagnostics company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO. The firm also offers pharmaceutical services like multi-analyte test development and clinical trial services. The company was founded in September 2009 and is headquartered in Alameda, CA.
Company Profile
SymbolOCX
Company NameOncoCyte
Listing DateJan 6, 2016
Issue Price6.25
Founded2009
CEOMr. Joshua Riggs
MarketNASDAQ
Employees46
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address15 Cushing
CityIrvine
ProvinceCalifornia
CountryUnited States of America
Zip Code92618
Phone1-949-409-7600
Websitehttp://www.oncocyte.com
Company Executives
- Name
- Position
- Salary
- Joshua Riggs
- Director, President and Chief Executive Officer
- 724.91K
- Ekkehard Schutz
- Chief Science Officer
- 575.17K
- James Liu
- Interim Principal Financial Officer, Senior Director, Controller and Principal Accounting Officer
- 304.51K
- Andrew Arno
- Chairman of the Board
- 112.54K
- Louis E. Silverman
- Lead Independent Director
- 97.70K
- Dr. Andrew J. Last, PhD
- Independent Director
- 92.86K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg